Table 5 Growth plate and articular cartilage related complication

Site

 Proximal humerus

1/17 (5.8%)

16/17 (94.2%)

2/17 (11.8%)

15/17 (88.2%)

 Supracetabular region

0/1 (0%)

1/1 (100%)

1/1 (100%)

0/1 (100%)

 Femur’s head

1/3 (33.3%)

2/3 (66.7%)

1/3 (33.3%)

2/3 (66.7%)

 Distal femur

1/15 (6.7%)

14/15 (93.3%)

2/15 (13.3%)

13/15 (86.7%)

 Patella

0/2 (0%)

2/2 (100%)

1/2 (50%)

1/2 (50%)

 Proximal tibia

1/17 (5.8%)

16/17 (94.2%)

3/17 (17.7%)

14/17 (82.3%)

 Distal tibia

1/2 (50%)

1/2 (50%)

0/2 (0%)

2/2 (100%)

 Talus

0/6 (0%)

6/6 (100%)

2/6 (33.3%)

4/6 (66.7%)

Stage

 Latent

1/17 (5.9%)

16/17 (94.1%)

2/17 (11.8%)

15/17 (88.2%)

 Active

1/34 (2.9%)

33/34 (97.1%)

4/34 (11.8%)

30/34 (88.2%)

 Aggressive

3/18 (16.7%)

15/18 (83.3%)

6/18 (33.3%)

12/18 (66.7%)

Physis status

 Open

5/21 (23.8%)

16/21 (76.2%)

3/21 (14.3%)

18/31 (58.1%)

 Closing

0/13 (0%)

13/13 (100%)

3/13 (23.1%)

10/13 (76.9%)

 Closed

0/35 (0%)

35/35 (100%)

6/35 (17.1%)

29/35 (82.9%)

Local adjuvants

 High-speed burr

5/64 (7.8%)

59/64 (92.2%)

10/64 (15.6%)

54/64 (84.4%)

 Phenol

3/39 (76.9%)

36/39 (92.3%)

1/39 (2.6%)

38/39 (97.4%)

 Liquid Nitrogen

1/10 (10%)

9/10 (90%)

4/10 (40%)

6/10 (60%)

Subchondral bone involvement

 None

2/55 (3.6%)

53/55 (96.4%)

7/55 (12.7%)

48/55 (87.3%)

 < 20%

2/6 (33.3%)

4/6 (66.7%)

2/6 (33.3%)

4/6 (66.7%)

 20 > 50%

1/5 (20%)

4/5 (80%)

2/5 (40%)

3/5 (60%)

 > 50%

0/3 (0%)

3/3 (100%)

1/3 (33.3%)

2/3 (66.7%)